Commentary on Institute of Medicine Marijuana Study
    As one of the final reviewers of the Institute of Medicine evaluation of marijuana, and as a physician who has studied this issue for over twenty years, I am aggravated by  the inaccurate portrayal of marijuana that the media has generally set forth.
    The IOM summary should be seen as a victory for opponents of smoked marijuana. It supported research into naturally occurring or synthetic cannabinoids, but it also stated that any research using any form of THC should culminate in the development of non-smoked forms of THC.
    The body of the study evaluated the health risks of marijuana in depth. It highlighted the effects on motor coordination, the respiratory system, the immune system, and  addiction. Furthermore, the study should serve as a death knell for the ballot initiatives and state laws allowing the prescribing of marijuana to virtually any patient.
    With regard to the use of smoked marijuana, the final recommendations speak for themselves: "Short-term use of smoked marijuana (less than six  months) for  patients with  debilitating  symptoms  (such  as  intractable  pain  or vomiting) must meet the following conditions:     The IOM findings are consistent with previous evaluations by the American Medical Association and the National Institutes of Health. They are a long way from wide support for the use of marijuana. If anything, the headlines should say, "Smoked marijuana as a medicine is dead."
 
Eric A. Voth, M.D., FACP
Chairman, The International Drug Strategy Institute
901 Garfield Topeka, Kansas  66606
785-354-9591
 
 
Top of Page          Index          Main Menu